Stäubli M, Roessler B, Köchli H P, Peheim E, Straub P W
Eur J Appl Physiol Occup Physiol. 1985;54(1):40-5. doi: 10.1007/BF00426296.
Following a 100 km race creatine kinase (CK) creatine kinase MB (CKMB) activities were serially measured in well trained athletes and compared with enzyme activities in patients with acute myocardial infarction (AMI). The half-time of disappearance of CK (CKt1/2) was 1.75 +/- 0.70 days in runners who trained within the 1st week after the race, and was 0.81 +/- 0.18 days in patients with AMI, P less than 0.005. CKt1/2 in runners was shorter (1.17 +/- 0.28 days) when no training was performed in the first postrace week. CKt1/2 was linearly correlated with age (P less than 0.01) in the runners but not in the patients. CKMBt1/2 was 1.30 and 1.11 days in two runners and 0.56 +/- 0.10 days in patients with AMI (P less than 0.05). In line with histologic and enzymatic findings in skeletal muscle of long distance runners as reported by other workers, our kinetic data provide further evidence that CK and CKMB are released from muscular compartments in runners other than those in patients with AMI.
在一场100公里赛跑后,对训练有素的运动员连续测量肌酸激酶(CK)和肌酸激酶同工酶(CKMB)的活性,并与急性心肌梗死(AMI)患者的酶活性进行比较。在赛后第一周内进行训练的跑步者中,CK的消失半衰期(CKt1/2)为1.75±0.70天,而AMI患者为0.81±0.18天,P<0.005。在赛后第一周不进行训练时,跑步者的CKt1/2较短(1.17±0.28天)。跑步者的CKt1/2与年龄呈线性相关(P<0.01),而患者则不然。两名跑步者的CKMBt1/2分别为1.30天和1.11天,AMI患者为0.56±0.10天(P<0.05)。正如其他研究人员报道的长跑运动员骨骼肌的组织学和酶学研究结果一样,我们的动力学数据进一步证明,CK和CKMB是从跑步者的肌肉组织中释放出来的,与AMI患者不同。